Terumo Corp  

(Public, TYO:4543)   Watch this stock  
Find more results for 4543
5,250.00
-290.00 (-5.23%)
May 23 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 5,230.00 - 5,830.00
52 week 2,756.00 - 5,830.00
Open 5,570.00
Vol / Avg. 2.40M/29.00
Mkt cap 996.86B
P/E 21.20
Div/yield 29.00/0.84
EPS 247.60
Shares 189.88M
Beta     -
Inst. own     -
Aug 1, 2013
Q1 2014 TERUMO CORP Earnings Release Add to calendar
Jun 26, 2013
TERUMO CORP Annual Shareholder Meeting (Japanese) Add to calendar
May 9, 2013
Full Year 2013 TERUMO CORP Earnings and New Mid-term Management Plan Presentation Webcast
May 9, 2013
Full Year 2013 TERUMO CORP Earnings, New Mid-term Management Plan Presentation and Webcast (Japanese) - Webcast
May 9, 2013
Full Year 2013 TERUMO CORP Earnings Release
  

Key stats and ratios

Q1 (Mar '13) 2013
Net profit margin 20.96% 11.70%
Operating margin 9.94% 13.35%
EBITD margin - 21.32%
Return on average assets 12.05% 6.43%
Return on average equity 21.76% 11.90%
Employees 18,112 -
Carbon Disclosure Rating - -

Address

2-44-1, Hatagaya
SHIBUYA-KU, TKY 151-0072
Japan
+81-3-33748111 (Phone)
+81-3-33748399 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

TERUMO CORPORATION operates in four business segment. The Hospital Products segment offers hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The Cardiac and Vascular Area segment is involved in the manufacture, purchase and sale of catheter systems, artificial heart and lungs, and artificial blood vessels, the manufacture and sale of therapeutic coils for cerebral aneurysm, sampling equipment and kits for platelet-rich plasma and concentrated bone-marrow cell, and large-bore sheaths. The Blood System segment is engaged in the manufacture, purchase and sale of blood transfusion-related products. The Healthcare segment offers healthcare related products. As of March 31, 2012, it had 79 subsidiaries and 2 associated companies. On February 28, 2013, it sold domiciliary oxygen and infusion pump business, including its two subsidiaries, to AIR WATER INC.

Officers and directors

Koji Nakao Chairman of the Board, Representative Director
Age: 65
Yutaro Shintaku President, Representative Director
Age: 56
Hideo Arase President & CEO of Subsidiary, Senior Executive Officer, Director
Age: 57
David Perez Senior Executive Officer, President & CEO of Subsidiary
Hiroshi Matsumura Executive Vice President, Director
Age: 58
Takayoshi Mimura Senior Managing Executive Officer, Chairman and General Manager of Subsidiary, Director
Age: 59
Akira Oguma Senior Managing Executive Officer, Director
Age: 60
Kosuke Matsumoto Executive Officer, Director of Human Resources
Ryo Nishihata Executive Officer, Director of Accounting
Richard Cappetta Executive Officer, President & CEO of Subsidiary